Intelligence Β· Clinical Development
Pipeline search results
Programs matching βrecombinantβ across our ClinicalTrials.gov index β phase, modality, sponsor, and trial IDs.
Quick answer
Showing 118 pipeline programs matching "recombinant" from NovaPharmaNews Clinical Development Intelligence β phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Recombinant human tissue kallikrein
DiaMedica Therapeutics
Acute Stroke
1 trial -
Recombinant von Willebrand factor (rVWF)
Takeda
Von Willebrand Disease
2 trials -
recombinant human erythropoietin
The First People's Hospital of Lianyungang
Lymphoma
1 trial -
recombinant human thrombopoietin
The First People's Hospital of Lianyungang
Immune Thrombocytopenia
1 trial -
recombinant human thrombopoietin (rhTPO); dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Purpura
1 trial -
recombinant human thrombopoietin (rhTPO); rituximab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Purpura
1 trial -
recombinant interferon alfa
United Therapeutics Europe Ltd
Melanoma (Skin)
1 trial -
rhIDU (recombinant human-Alpha-L-Iduronidase)
BioMarin Pharmaceutical Australia Pty Ltd
Mucopolysaccharidosis I
1 trial -
rituximab; recombinant human thrombopoietin (rhTPO)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Purpura
1 trial -
von Willebrand factor (Recombinant)
Takeda
Von Willebrand Disease
1 trial -
Aerosolized, Recombinant Alpha 1-Antitrypsin
Takeda
Alpha1-antitrypsin Deficiency
2 trials -
BMN 190 recombinant human tripeptidyl peptidase-1 (rhTPP1)
BioMarin Pharmaceutical Australia Pty Ltd
Jansky-Bielschowsky Disease
1 trial -
CTP-VLP-002
CanSino Biologics
Poliomyelitis
1 trial -
JSVCT099
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
KLWS-V502-02
BRIGHT MINDS BIOSCIENCES INC.
Human Papilloma Virus Infection
1 trial -
Multivalent recombinant OspA Lyme Borreliosis Vaccine
Takeda
Prophylaxis of Lyme Borreliosis
1 trial -
Part1:Recombinant two-component COVID-19 vaccine (CHO cell)
Jian Li
COVID-19
1 trial -
Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Psoriasis
1 trial -
Recombinant Anti-IL-1Ξ² Humanized Monoclonal Antibody Injection 100 mg
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Gout Arthritis
1 trial -
Recombinant COVID-19 Vaccine (CHO cell)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
Recombinant COVID-19 Vaccine (CHO cellοΌNVSI-06-08)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
Recombinant COVID-19 Vaccine (CHO cellοΌNVSI-06-09)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Recombinant Human Endostatin Injection
The First People's Hospital of Lianyungang
Locally Advanced Squamous Non-small Cell Lung Cancer
1 trial -
Recombinant Human Erythropoiesis Injection (CHO cell)
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Renal Failure With Hemodialysis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs β not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars β improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes β use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.